These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 34684638)

  • 21. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.
    Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS
    Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine].
    Han WB; Liu YL; Wan YG; Sun W; Tu Y; Yang JJ; Wu W; He WM; Yao J
    Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2425-2432. PubMed ID: 28840678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microbiota metabolites: Pivotal players of cardiovascular damage in chronic kidney disease.
    Cosola C; Rocchetti MT; Cupisti A; Gesualdo L
    Pharmacol Res; 2018 Apr; 130():132-142. PubMed ID: 29518493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emodin via colonic irrigation modulates gut microbiota and reduces uremic toxins in rats with chronic kidney disease.
    Zeng YQ; Dai Z; Lu F; Lu Z; Liu X; Chen C; Qu P; Li D; Hua Z; Qu Y; Zou C
    Oncotarget; 2016 Apr; 7(14):17468-78. PubMed ID: 27003359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-chain fatty acids: a link between prebiotics and microbiota in chronic kidney disease.
    Esgalhado M; Kemp JA; Damasceno NR; Fouque D; Mafra D
    Future Microbiol; 2017 Nov; 12():1413-1425. PubMed ID: 29027814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dietary Fiber and Gut Microbiota in Renal Diets.
    Camerotto C; Cupisti A; D'Alessandro C; Muzio F; Gallieni M
    Nutrients; 2019 Sep; 11(9):. PubMed ID: 31505733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut microbiota and chronic kidney disease: implications for novel mechanistic insights and therapeutic strategies.
    Pan W; Kang Y
    Int Urol Nephrol; 2018 Feb; 50(2):289-299. PubMed ID: 28849345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Interplay between the Gut Microbiome and the Immune System in the Context of Infectious Diseases throughout Life and the Role of Nutrition in Optimizing Treatment Strategies.
    Wiertsema SP; van Bergenhenegouwen J; Garssen J; Knippels LMJ
    Nutrients; 2021 Mar; 13(3):. PubMed ID: 33803407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic kidney disease, uremic milieu, and its effects on gut bacterial microbiota dysbiosis.
    Chaves LD; McSkimming DI; Bryniarski MA; Honan AM; Abyad S; Thomas SA; Wells S; Buck M; Sun Y; Genco RJ; Quigg RJ; Yacoub R
    Am J Physiol Renal Physiol; 2018 Sep; 315(3):F487-F502. PubMed ID: 29693447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Low-Protein Diet and Inulin on Microbiota and Clinical Parameters in Patients with Chronic Kidney Disease.
    Lai S; Molfino A; Testorio M; Perrotta AM; Currado A; Pintus G; Pietrucci D; Unida V; La Rocca D; Biocca S; Desideri A
    Nutrients; 2019 Dec; 11(12):. PubMed ID: 31818021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of the Gut Microbiota by Resistant Starch as a Treatment of Chronic Kidney Diseases: Evidence of Efficacy and Mechanistic Insights.
    Snelson M; Kellow NJ; Coughlan MT
    Adv Nutr; 2019 Mar; 10(2):303-320. PubMed ID: 30668615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gut Microbiota and Intestinal Epithelial Myd88 Signaling Are Crucial for Renal Injury in UUO Mice.
    Watanabe IKM; Andrade-Silva M; Foresto-Neto O; Felizardo RJF; Matheus MAC; Silva RC; Cenedeze MA; Honda TSB; Perandini LAB; Volpini RA; Pacheco-Silva A; Câmara NOS
    Front Immunol; 2020; 11():578623. PubMed ID: 33414781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Gut microbiota and kidney diseases : dangerous liaisons?].
    Ghajarzadeh-Wurzner A; Berney M; Teta D; Genton L; Pruijm M
    Rev Med Suisse; 2018 Feb; 14(595):422-425. PubMed ID: 29465874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Research progress in the role of gut microbiota in acute kidney injury.
    Chen T; Chang C; Hou B; Qiu L; Sun H; Zhu X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 49(3):385-391. PubMed ID: 38970512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gut microbiome in chronic kidney disease.
    Wing MR; Patel SS; Ramezani A; Raj DS
    Exp Physiol; 2016 Apr; 101(4):471-7. PubMed ID: 26337794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The gut microbiome, kidney disease, and targeted interventions.
    Ramezani A; Raj DS
    J Am Soc Nephrol; 2014 Apr; 25(4):657-70. PubMed ID: 24231662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gut microbiota and inflammation in chronic kidney disease and their roles in the development of cardiovascular disease.
    Onal EM; Afsar B; Covic A; Vaziri ND; Kanbay M
    Hypertens Res; 2019 Feb; 42(2):123-140. PubMed ID: 30504819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intestinal microbiota and diabetic kidney diseases: the Role of microbiota and derived metabolites inmodulation of renal inflammation and disease progression.
    Mosterd CM; Kanbay M; van den Born BJH; van Raalte DH; Rampanelli E
    Best Pract Res Clin Endocrinol Metab; 2021 May; 35(3):101484. PubMed ID: 33546983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gut Microbiota, in the Halfway between Nutrition and Lung Function.
    Espírito Santo C; Caseiro C; Martins MJ; Monteiro R; Brandão I
    Nutrients; 2021 May; 13(5):. PubMed ID: 34069415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nutritional Modulation of the Microbiome and Immune Response.
    Burr AHP; Bhattacharjee A; Hand TW
    J Immunol; 2020 Sep; 205(6):1479-1487. PubMed ID: 32900885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.